Inventor · disambiguated record
Lena Mareen Kranz
Also filed as: KRANZ LENA · KRANZ LENA MAREEN
3 granted patents·13 pending applications·19 citations·filing 2013–2023
65Inventor score
Files withBioNTech SE13BIONTECH RNA PHARMACEUTICALS GMBH2TRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ AD1
Top patents by PatentIndex Score
16 records- 0189US11559587B2RNA formulation for immunotherapyBioNTech SE·Filed 2019·Granted Jan 24, 2023·3 cites·44 claims
- 0289US10485884B2RNA formulation for immunotherapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2013·Granted Nov 26, 2019·16 cites·39 claims
- 0372US2023226217A1Rna formulation for immunotherapyTRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ AD·Filed 2022·Application pending·0 cites
- 0468US2023330198A1Rna for treatment of autoimmune diseasesBioNTech SE·Filed 2023·Application pending·0 cites
- 0560US2025295744A1Treatment involving non-immunogenic rna for antigen vaccination and pd-1 axis binding antagonistsBioNTech SE·Filed 2022·Application pending·0 cites
- 0657US11701413B2RNA for treatment of autoimmune diseasesBioNTech SE·Filed 2018·Granted Jul 18, 2023·0 cites·8 claims
- 0755US2025295746A1Therapeutic rna for lung cancerBioNTech SE·Filed 2022·Application pending·0 cites
- 0854US2023145774A1Treatment involving non-immunogenic rna for antigen vaccinationBioNTech SE·Filed 2021·Application pending·0 cites
- 0953US2024335511A1Therapeutic rna for treating cancerBioNTech SE·Filed 2021·Application pending·0 cites
- 1053US2024415946A1Therapeutic rna for lung cancerBioNTech SE·Filed 2022·Application pending·0 cites
- 1152US2024041999A1Therapeutic RNA for Treating CancerBioNTech SE·Filed 2021·Application pending·0 cites
- 1249US2023117803A1Treatment involving antigen vaccination and binding agents binding to pd-l1 and cd137BioNTech SE·Filed 2021·Application pending·0 cites
- 1347US2024390462A1Treatment Schedule for Cytokine ProteinsBioNTech SE·Filed 2021·Application pending·0 cites
- 1447US2022143144A1Treatment involving interleukin-2 (il2) and interferon (ifn)BioNTech SE·Filed 2020·Application pending·0 cites
- 1545US2021113606A1Treatment using cytokine encoding rnaBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 1644US2022356223A1IL2 AgonistsBioNTech SE·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lena Mareen Kranz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →